Brain Perfusion in Adult Patients with Acute Myeloblastic Leukemia before and after Cytosine Arabinoside
✍ Scribed by Romain Modzelewski; Stéphane Lepretre; Olivier Martinaud; Didier Hannequin; Anne Hitzel; Marie-Odile Habert; Hervé Tilly; Pierre Vera
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 341 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1536-1632
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Peripheral nerve toxicity has been reported but is not a commonly recognized complication of high dose cytosine arabinoside (HDAC) therapy. This study was undertaken to estimate the prevalence and describe the clinical spectrum of acute polyneuropathy associated with HDAC therapy fo
## Abstract ## BACKGROUND Drug resistance and early disease recurrence were major contributing factors in the limited survival of patients with acute lymphocytic leukemia (ALL). New chemotherapeutic agents and drug combinations were employed in refractory patients to overcome drug resistance. ##